(Q43949822)

28 November 2017

Lack of bioequivalence of ciprofloxacin when administered with calcium-fortified orange juice: a new twist on an old interaction (English)

1 reference

28 November 2017

Ashley L Neuhofel

1

1 reference

28 November 2017

John H Wilton

2

1 reference

28 November 2017

Jennifer M Victory

3

1 reference

28 November 2017

Linda G Hejmanowsk

4

1 reference

28 November 2017

Guy W Amsden

5

1 reference

28 November 2017

1 April 2002

1 reference

The Journal of Clinical Pharmacology

28 November 2017

1 reference

28 November 2017

42

1 reference

28 November 2017

4

1 reference

28 November 2017

461-466

1 reference

Interaction between ciprofloxacin and metal cations: its influence on physicochemical characteristics and antibacterial activity.

28 November 2017

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011391

Effects of aluminum and magnesium antacids and ranitidine on the absorption of ciprofloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011391

A comparison of the Two One-Sided Tests Procedure and the Power Approach for assessing the equivalence of average bioavailability

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011391

Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011391

Pneumococcal resistance: the treatment challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011391

Active intestinal elimination of ciprofloxacin in rats: modulation by different substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011391

Pharmacodynamics of moxifloxacin, levofloxacin and sparfloxacin against Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011391

Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011391

Pharmacodynamics of fluoroquinolones against Streptococcus pneumoniae in patients with community-acquired respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011391

Effects of dairy products on the oral bioavailability of moxifloxacin, a novel 8-methoxyfluoroquinolone, in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011391

10.1177/00912700222011391

21 January 2018

Identifiers

DOI

1 reference

28 November 2017

1 reference